Landmark Trials Supporting PD-1 Checkpoint Inhibition for Advanced CSCC

Landmark Trials Supporting PD-1 Checkpoint Inhibition for Advanced CSCC


Published

January 4, 2019

Created by

CMEducation Resources symposium

Related Presenters

Karl Lewis, MD

Karl Lewis, MD

Associate Professor of MedicineDivision of Medical OncologyDirector, Cutaneous Oncology ProgramUniversity of Colorado School of Medicine